The distribution of HER2 amplification among histotypes of cervical adenocarcinomas has not yet been fully investigated, although IHC studies demonstrated that endocervical adenocarcinomas of usual type had a HER2 positive frequency of 1.8% [5], which was much lower than in GAC [32]. Here, ERBB2 is linked to cervical adenocarcinoma.